medigraphic.com
ISSN 1560-4381 (Print)

2020, Number 3

<< Back Next >>

Correo Científico Médico 2020; 24 (3)

Approach to pathogenesis of COVID-19 according to virus-host interaction

Ortiz SJC, Chacón BD, Serra HE, Ochoa TI, Serra PLC, Parra HC

Language: Spanish
References: 32
Page: 997-1012
PDF size: 243.50 Kb.


ABSTRACT

More than 100 years after the 1918 influenza outbreak, humanity is once again facing a pandemic, which has spread to all continents and has forced us to understand it and learn to live with it. SARS-Cov-2 coronavirus, that causes COVID-19, has peculiar characteristics from the epidemiological and clinical points of view, which motivated us to search the bases of virus-host interaction for an understanding of a probable pathogenic evolution that corresponds to the current knowledge of the disease; in this mini review of the topic we try to integrate aspects of the biological basis of virus disease, the current theory of pathogenesis, some essential aspects of virology, immunological basis and the most used diagnostic tests.


REFERENCES

  1. WHO. Novel Coronavirus (2019-nCoV) situation reports.Geneva:WHO;01/01/2020 [citado 23 /01/ 2020]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

  2. Ye Yi, Lagniton P, Ye S, Li E , Ren-He Xu. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020[citado 18 /05/20];16(10): 1753–1766. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098028/

  3. Bennett JE, Dolin R,Blaser M. Mandell, Douglas y Bennett. Enfermedades infecciosas. Principios y prácticas infecciosas. Principios y práctica. 8va ed. España:Elsevier;2015

  4. Kenneth McIntosh , Stanley Perlman: Coronavirus, incluido el síndrome respiratorio agudo grave (SRAG) y el síndrome respiratorio de Oriente Medio (SROM).En :Mandell, Douglas y Bennett enfermedades infecciosas, Principios y práctica. 8va . Volumen 1.Disponible en: https://www.clinicalkey.es/#!/browse/book/3-s2.0-C20140042335

  5. Ling Lin, Lianfeng Lu, Wei Cao & Taisheng Li. (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020[citado 15/02/2020]; 9(1): 727-732. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170333/

  6. Tobias M. Defensa contra la infección mediada por células .En: Mandell, Douglas y Bennett. Enfermedades infecciosas. Principios y práctica.8va ed. Vol 1.España: Elsevier España;2015.

  7. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z. et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020[citado 04/04/ 2020];382:1177-1179.Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMc2001737

  8. Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020[citado 04/04/ 2020];20(4):411–412. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128099/

  9. Wölfel R,Corman VC,Guggemos W,Niemeyer D,Ehmann R,Drosten C.et.al.Virological assessment of hospitalized patients with COVID-2019 . Nature .2020 [citado 04 /04/ 2020];581:465–469. Disponible en: https://www.nature.com/articles/s41586-020-2196-x

  10. Liu Y, Yan L-M, Wan L, Xiang T-X, Le A, Liu J-M. et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020[citado 04 /04/ 2020];20(6):656-657.Disponible en: https://pubmed.ncbi.nlm.nih.gov/32199493/

  11. WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. 2020. Disponible en: https://www.who.int/publications/i/item/10665-331501

  12. Li Z, Yi Y, Luo X, Wei C, Yongchen Z, Jing W, et al. Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis. J Med Virol.2020 [citado 04/04/ 2020] .Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25727

  13. Yan Rong G, Qing Dong C, Zhong Si H, De-Yun W, Yan Y, Kai-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019(COVID-19) outbreak –an update on the status. Mil Med Res. 2020[citado 04/04/ 2020] 7(1):11.Disponible en: https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-020-00240-0

  14. Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y.et al. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020[citado 04/04/ 2020]; 17:765–767. Disponible en: https://www.nature.com/articles/s41423-020-0374-2

  15. Xiaowei Li, Manman G, Yizhao P ,Liesu M, Shemin L,et al. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharma Analysis. 2020 [citado 04/04/ 2020];10(2):102-108.Disponible en: https://www.sciencedirect.com/science/article/pii/S2095177920302045

  16. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama.2020[citado 04 /04/ 2020];323(11):1061-1069.Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2761044

  17. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) –China, 2020.CCDC Weekly. 2020[citado 21/07/2020];2(x):1-10. Disponible en: https://www.publichealthontario.ca/-/media/documents/ncov/research-cdc-epidemiological-characteristics.pdf?la=en

  18. Chen N , Zhou M, Dong X, Qu J, Fengyun Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet.2020[citado 20/05/2020]; 395(10223):507-513.Disponible en: https://pubmed.ncbi.nlm.nih.gov/32007143/

  19. Field Briefing: Diamond Princess COVID-19 Cases[citado 04 /03/ 2020]. Disponible en: https://www.niid.go.jp/niid/en/2019-ncov-e/9417-covid-dp-fe-02.html

  20. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020[citado 04 /03/ 2020];395(10223):497-506.Disponible en: https://pubmed.ncbi.nlm.nih.gov/31986264/

  21. Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al .[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020[citado 04 /03/ 2020];43(0):005.Disponible en: https://pubmed.ncbi.nlm.nih.gov/32026671/

  22. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020 [citado 16 /03/ 2020]; 25(10):2000180. Disponible en: https://www.eurosurveillance.org/content/10.2807/15607917.ES.2020.25.10.2000180.

  23. Heshui S, Xiaoyu H, Nanchuan J, Yukun C,Osamah A, Jin G, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.Lancet.2020 [citado 16 /03/ 2020];20(4):425-434.Disponible en: https://www.thelancet.com/article/S1473-3099(20)30086-4/fulltext

  24. Long B, Brady WJ, Koyfman A. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020 [citado 16 /03/ 2020]; 38(7): 1504–1507. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165109/

  25. Wei Z, Zheng Z, Xingzhi X, Qizhi Y, Jun L. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR. 2020[citado 16 /03/ 2020];214(5):1072-1077.Disponible en: https://www.ajronline.org/doi/10.2214/AJR.20.22976

  26. Zhao J, Yuan Q, Wang H, Yingying S, Xin W, Jing Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.Clin Infect Dis. 2020[citado 30 /03/ 2020];71(16):2027-2034.Disponible en: https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa344/5812996

  27. Wölfel R, Corman VM, Guggemos W, Katrin Z, Christian D, Clemens W, et al. Virological assessment of hospitalized patients withCOVID-2019. Nature. 2020. [citado 16 /03/ 2020];581(7809):465-469. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32235945/

  28. Xing Y, Mo P, Xiao Y, Zhao O, Zhang Y, Wang F. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19). 2020.Euro Surveill. 2020 [citado 16 /03/ 2020];25(10):2000191. Disponble en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078824/

  29. Zheng S, Fan J, Yu F, Xiaoyang L,Bin L,Qi W, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China,2020: retrospective cohort study. BMJ. 2020[citado 16 /03/ 2020];369: 1443. Disponible en: https://www.bmj.com/content/369/bmj.m1443

  30. Guo L, Ren L, Yang S, Yingying W, Chao W, Yan X, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020 [citado 16 /03/ 2020];20(60).Disponible en: https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa310/5810754

  31. Wei Jie G, Zheng Yi N, Yu H, Wen Hua L, Chun-Quan O, Jian-Xing H, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 [citado 16 /03/ 2020];382:1708-1720.Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa2002032

  32. CDC. Criteria for Return to Work for Healthcare Personnel with Suspected or Confirmed COVID-19 (Interim Guidance).2020.Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html




2020     |     www.medigraphic.com